Found 12 results
[ Author(Desc)] Title Type Year
Filters: Author is William H. Bisson  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
W. H. Bisson, Editorial: computational chemogenomics in drug design and discovery., Current topics in medicinal chemistry, vol. 12, p. 1867, 2012.
W. H. Bisson, Drug repurposing in chemical genomics: can we learn from the past to improve the future?, Current topics in medicinal chemistry, vol. 12, pp. 1883–1888, 2012.
W. H. Bisson, Westera, G., P Schubiger, A., and Scapozza, L., Homology modeling and dynamics of the extracellular domain of rat and human neuronal nicotinic acetylcholine receptor subtypes $\alpha$4$\beta$2 and $\alpha$7, Journal of molecular modeling, vol. 14, pp. 891–899, 2008.
W. H. Bisson, Zhang, Z., Welsh, K., Huang, J. - W., Ryan, J., Reed, J. C., and Pellecchia, M., Binding Properties of the C-terminal Domain of VIAF, Chemical biology & drug design, vol. 72, pp. 331–336, 2008.
W. H. Bisson, Cheltsov, A. V., Bruey-Sedano, N., Lin, B., Chen, J., Goldberger, N., May, L. T., Christopoulos, A., Dalton, J. T., Sexton, P. M., and , Discovery of antiandrogen activity of nonsteroidal scaffolds of marketed drugs, Proceedings of the National Academy of Sciences, vol. 104, pp. 11927–11932, 2007.
W. H. Bisson, Scapozza, L., Westera, G., Mu, L., and Schubiger, P. A., Ligand selectivity for the acetylcholine binding site of the rat $\alpha$4$\beta$2 and $\alpha$3$\beta$4 nicotinic subtypes investigated by molecular docking, Journal of medicinal chemistry, vol. 48, pp. 5123–5130, 2005.
W. H. Bisson, Abagyan, R., and Cavasotto, C. N., Molecular basis of agonicity and antagonicity in the androgen receptor studied by molecular dynamics simulations, Journal of Molecular Graphics and Modelling, vol. 27, no. 4, pp. 452 - 458, 2008.
W. H. Bisson, Koch, D. C., Donnell, E. F. ’, Khalil, S. M., Kerkvliet, N. I., Tanguay, R. L., Abagyan, R., and Kolluri, S., Modeling of the Aryl Hydrocarbon Receptor (AhR) Ligand Binding Domain and Its Utility in Virtual Ligand Screening to Predict New AhR Ligands, Journal of Medicinal Chemistry, vol. 52, no. 18, pp. 5635 - 5641, 2009.
W. H. Bisson, Environmental immune disruptors, inflammation and carcinogenesis: A state of the science and new horizons, Toxicology Letters, vol. 280, pp. S9 - S10, 2017.
W. H. Bisson, Amedei, A., Memeo, L., Forte, S., and Felsher, D. W., Tumor-Promoting/Associated Inflammation and the Microenvironment: A State of the Science and New Horizons, Hoboken, NJ, USA: John Wiley & Sons, Inc., 2018, pp. 473 - 510.
W. H. Bisson, Koch, D. C., O'Donnell, E. F., Khalil, S. M., Kerkvliet, N. I., Tanguay, R. L., Abagyan, R., and Kolluri, S. Kumar, Modeling of the aryl hydrocarbon receptor (AhR) ligand binding domain and its utility in virtual ligand screening to predict new AhR ligands., J Med Chem, vol. 52, no. 18, pp. 5635-41, 2009.
W. H. Bisson, Koch, D. C., O'Donnell, E. F., Khalil, S. M., Kerkvliet, N. I., Tanguay, R. L., Abagyan, R., and Kolluri, S. Kumar, Modeling of the aryl hydrocarbon receptor (AhR) ligand binding domain and its utility in virtual ligand screening to predict new AhR ligands, Journal of medicinal chemistry, vol. 52, pp. 5635–5641, 2009.